FinMen’s Impactful Delivery in the Pharma Industry

Company Background:

Manufacturer of pharmaceutical formulations including tablets, syrups, capsules, and ointments, covering various therapeutic classes such as anti-diabetics and anti-hypertensive drugs.

Problem:

The company’s downgrade to sub-investment grade, attributed to the full utilization of limits, led to accounts being frozen by the lenders.

Solution:

Advised the client for re-rating after thoroughly understanding and analyzing liquidity based on bank account statements. Additionally, presented both gross utilization and net utilization (current account balance) along with bank statements to address the liquidity concern comprehensively.

Impact:

With a comprehensive approach to conduct a deep dive for solutions, Finmen aided the client in securing an investment-grade rating. This not only reinstated their limits but also aided an enhancement in limits for further support in business growth, all accomplished in a very short span of time to minimize the impact on the business.

Open chat
Hello 👋
Can we help you?